349 related articles for article (PubMed ID: 34053456)
1. High-fat diet impairs ferroptosis and promotes cancer invasiveness via downregulating tumor suppressor ACSL4 in lung adenocarcinoma.
Zhang Y; Li S; Li F; Lv C; Yang QK
Biol Direct; 2021 May; 16(1):10. PubMed ID: 34053456
[TBL] [Abstract][Full Text] [Related]
2. ACSL4 suppresses glioma cells proliferation via activating ferroptosis.
Cheng J; Fan YQ; Liu BH; Zhou H; Wang JM; Chen QX
Oncol Rep; 2020 Jan; 43(1):147-158. PubMed ID: 31789401
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of ACSL4 attenuates ferroptotic damage after pulmonary ischemia-reperfusion.
Xu Y; Li X; Cheng Y; Yang M; Wang R
FASEB J; 2020 Dec; 34(12):16262-16275. PubMed ID: 33070393
[TBL] [Abstract][Full Text] [Related]
4. LPCAT3 Is Transcriptionally Regulated by YAP/ZEB/EP300 and Collaborates with ACSL4 and YAP to Determine Ferroptosis Sensitivity.
Cui J; Wang Y; Tian X; Miao Y; Ma L; Zhang C; Xu X; Wang J; Fang W; Zhang X
Antioxid Redox Signal; 2023 Sep; 39(7-9):491-511. PubMed ID: 37166352
[No Abstract] [Full Text] [Related]
5. Clinical and Biological Significances of a Ferroptosis-Related Gene Signature in Lung Cancer Based on Deep Learning.
Yang X; Hu X; Guo N
Comput Math Methods Med; 2022; 2022():6495301. PubMed ID: 36060648
[TBL] [Abstract][Full Text] [Related]
6. Identification of ACSL4 as a biomarker and contributor of ferroptosis.
Yuan H; Li X; Zhang X; Kang R; Tang D
Biochem Biophys Res Commun; 2016 Sep; 478(3):1338-43. PubMed ID: 27565726
[TBL] [Abstract][Full Text] [Related]
7. ACSL4-dependent ferroptosis does not represent a tumor-suppressive mechanism but ACSL4 rather promotes liver cancer progression.
Grube J; Woitok MM; Mohs A; Erschfeld S; Lynen C; Trautwein C; Otto T
Cell Death Dis; 2022 Aug; 13(8):704. PubMed ID: 35963845
[TBL] [Abstract][Full Text] [Related]
8. Tumor-suppressive functions of long-chain acyl-CoA synthetase 4 in gastric cancer.
Ye X; Zhang Y; Wang X; Li Y; Gao Y
IUBMB Life; 2016 Apr; 68(4):320-7. PubMed ID: 26949059
[TBL] [Abstract][Full Text] [Related]
9. ACSL4: a double-edged sword target in multiple myeloma, promotes cell proliferation and sensitizes cell to ferroptosis.
Zhang J; Liu Y; Li Q; Zuo L; Zhang B; Zhao F; Fan F; Luo S; Hu Y; Sun C
Carcinogenesis; 2023 May; 44(3):242-251. PubMed ID: 36999754
[TBL] [Abstract][Full Text] [Related]
10. Ischemia-induced ACSL4 activation contributes to ferroptosis-mediated tissue injury in intestinal ischemia/reperfusion.
Li Y; Feng D; Wang Z; Zhao Y; Sun R; Tian D; Liu D; Zhang F; Ning S; Yao J; Tian X
Cell Death Differ; 2019 Nov; 26(11):2284-2299. PubMed ID: 30737476
[TBL] [Abstract][Full Text] [Related]
11. Tumor suppressor miR-424-5p abrogates ferroptosis in ovarian cancer through targeting ACSL4.
Ma LL; Liang L; Zhou D; Wang SW
Neoplasma; 2021 Jan; 68(1):165-173. PubMed ID: 33038905
[TBL] [Abstract][Full Text] [Related]
12. Knockdown of SHP2 attenuated LPS-induced ferroptosis via downregulating ACSL4 expression in acute lung injury.
Li B; Wang Z; Yuan J; Liang D; Cheng Y; Wang Z
Allergol Immunopathol (Madr); 2023; 51(3):143-152. PubMed ID: 37169572
[TBL] [Abstract][Full Text] [Related]
13. Long non-coding RNA NEAT1 regulates ferroptosis sensitivity in non-small-cell lung cancer.
Wu H; Liu A
J Int Med Res; 2021 Mar; 49(3):300060521996183. PubMed ID: 33730930
[TBL] [Abstract][Full Text] [Related]
14. FUNDC1 insufficiency sensitizes high fat diet intake-induced cardiac remodeling and contractile anomaly through ACSL4-mediated ferroptosis.
Pei Z; Liu Y; Liu S; Jin W; Luo Y; Sun M; Duan Y; Ajoolabady A; Sowers JR; Fang Y; Cao F; Xu H; Bi Y; Wang S; Ren J
Metabolism; 2021 Sep; 122():154840. PubMed ID: 34331963
[TBL] [Abstract][Full Text] [Related]
15. miRNA-17-92 protects endothelial cells from erastin-induced ferroptosis through targeting the A20-ACSL4 axis.
Xiao FJ; Zhang D; Wu Y; Jia QH; Zhang L; Li YX; Yang YF; Wang H; Wu CT; Wang LS
Biochem Biophys Res Commun; 2019 Jul; 515(3):448-454. PubMed ID: 31160087
[TBL] [Abstract][Full Text] [Related]
16. Hsp90 induces Acsl4-dependent glioma ferroptosis via dephosphorylating Ser637 at Drp1.
Miao Z; Tian W; Ye Y; Gu W; Bao Z; Xu L; Sun G; Li C; Tu Y; Chao H; Lam SM; Liu N; Ji J
Cell Death Dis; 2022 Jun; 13(6):548. PubMed ID: 35697672
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-670-3p suppresses ferroptosis of human glioblastoma cells through targeting ACSL4.
Bao C; Zhang J; Xian SY; Chen F
Free Radic Res; 2021 Jul; 55(7):853-864. PubMed ID: 34323631
[TBL] [Abstract][Full Text] [Related]
18. ACSL4 exacerbates ischemic stroke by promoting ferroptosis-induced brain injury and neuroinflammation.
Cui Y; Zhang Y; Zhao X; Shao L; Liu G; Sun C; Xu R; Zhang Z
Brain Behav Immun; 2021 Mar; 93():312-321. PubMed ID: 33444733
[TBL] [Abstract][Full Text] [Related]
19. MitoQ protects against carbon tetrachloride-induced hepatocyte ferroptosis and acute liver injury by suppressing mtROS-mediated ACSL4 upregulation.
Tao L; Xue YF; Sun FF; He X; Wang HQ; Tong CC; Zhang C; Xu DX; Chen X
Toxicol Appl Pharmacol; 2024 May; 486():116914. PubMed ID: 38522585
[TBL] [Abstract][Full Text] [Related]
20. Liver-specific knockdown of long-chain acyl-CoA synthetase 4 reveals its key role in VLDL-TG metabolism and phospholipid synthesis in mice fed a high-fat diet.
Singh AB; Kan CFK; Kraemer FB; Sobel RA; Liu J
Am J Physiol Endocrinol Metab; 2019 May; 316(5):E880-E894. PubMed ID: 30721098
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
